AJGP
HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Geriatr Psychiatry 13:1014-1021, November 2005
© 2005 American Association for Geriatric Psychiatry
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a Colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hirschman, K. B.
Right arrow Articles by Karlawish, J. H.T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hirschman, K. B.
Right arrow Articles by Karlawish, J. H.T.

Regular Article

Would Caregivers of Alzheimer Disease Patients Involve Their Relative in a Decision to Use an AD-Slowing Medication?

Karen B. Hirschman, Ph.D., M.S.W., Colette M. Joyce, M.A., Bryan D. James, M.Bioethics, Sharon X. Xie, Ph.D., David J. Casarett, M.D., M.A., and Jason H.T. Karlawish, M.D.

Received Aug. 30, 2004; revision received March 17, 2005; accepted May 4, 2005. From the School of Nursing, Division of Biobehavioral and Health Sciences (KBH), the Dept. of Sociology (CMJ), the Dept. of Medicine (BDJ, DJC, JHTK), the Division of Geriatrics (BDJ, DJC, JHTK), the Dept. of Biostatistics and Epidemiology (SXX), the Leonard Davis Institute of Health Economics (DJC, JHTK), the Center for Bioethics (DJC, JHTK), the Alzheimer’s Disease Center (SXX, JHTK), and The Institute on Aging (KBH, DJC, JHTK), at the Univ. of Pennsylvania and The Center for Health Equity Research and Promotion at the Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania (DJC). Send correspondence and reprint requests to Dr. Karen Hirschman, Institute on Aging, 3615 Chestnut Street, Philadelphia, PA 19104. e-mail: hirschk{at}nursing.upenn.edu
© 2005 American Association for Geriatric Psychiatry

Objectives: The authors examined the factors associated with 1) caregivers’ willingness to involve a relative with Alzheimer disease (AD) in a decision to use an AD-slowing treatment; and 2) how caregivers would resolve a disagreement over this decision with the their relative. Methods: This was a cross-sectional interview study of 102 caregivers of patients with mild-to-severe–stage AD, enrolled in a University Memory Disorders Clinic. Results: Forty-four percent of caregivers (45/102) said that his or her relative would participate in a decision to use an AD-slowing treatment. Logistic regression showed that having less dementia severity, being a female caregiver, and a spousal relationship were all associated with caregivers’ involving their relative in this decision. Among the caregivers who said they would involve their relative, the majority said they would resolve disagreements over whether to use the treatment in favor of what the patient wanted, versus what the family wanted for the patient. Male caregivers were less likely to resolve disagreements in favor of the patients’ preferences. Conclusion: Although most caregivers of patients in mild-to-moderate stages would include these patients in an AD treatment decision, certain caregiver characteristics, such as gender and relationship, are associated with not involving patients in this decision. Physicians working with dementia patients and their family members should take these characteristics into account when discussing treatment options and work with patient–caregiver dyads to improve the communication of preferences.

Key Words: Alzheimer Disease • Family Caregivers • ACE Inhibitors




This article has been cited by other articles:


Home page
AJGPHome page
E. L. O'Neal, J. R. Adams, G. J. McHugo, A. D. Van Citters, R. E. Drake, and S. J. Bartels
Preferences of Older and Younger Adults With Serious Mental Illness for Involvement in Decision-Making in Medical and Psychiatric Settings
Am J Geriatr Psychiatry, October 1, 2008; 16(10): 826 - 833.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
J. Karlawish, S. Y. H. Kim, D. Knopman, C. H. van Dyck, B. D. James, and D. Marson
The Views of Alzheimer Disease Patients and Their Study Partners on Proxy Consent for Clinical Trial Enrollment
Am J Geriatr Psychiatry, March 1, 2008; 16(3): 240 - 247.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
K. B. Hirschman, J. M. Kapo, and J. H.T. Karlawish
Why Doesn't a Family Member of a Person With Advanced Dementia Use a Substituted Judgment When Making a Decision for That Person?
Am J Geriatr Psychiatry, August 1, 2006; 14(8): 659 - 667.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
K. Yaffe
Research and Care of Patients With Dementia: Moving Beyond Memory Loss
Am J Geriatr Psychiatry, November 1, 2005; 13(11): 921 - 925.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
Copyright © 2005 American Association for Geriatric Psychiatry